Table 2 Number (valid %) of patients in whom cysts disappeared out of the total who had cysts of that type at baseline (%)

	Active cysts			Transitional cysts			Calcifications
	Albendazole	Placebo	p Value for χ² test	Albendazole	Placebo	p Value for χ² test	Albendazole	Placebo	p Value for χ² test
All locations
Baseline	0/59 (0)	0/57 (0)	Referent	0/49 (0)	0/54 (0)	Referent	0/38 (0)	0/32 (0)	Referent
1 month	18/58 (31.0)	4/55 (7.3)	0.001	13/47 (27.0)	12/52 (23.1)	0.600	30/37 (81.1)	20/30 (66.7)	0.178
6 month	18/51 (35.3)	6/50 (12.0)	0.006	22/42 (52.4)	19/49 (38.8)	0.194	28/34 (82.4)	18/28 (64.3)	0.106
12 month	20/53 (37.7)	10/50 (20.0)	0.048	23/42 (54.8)	27/51 (52.9)	0.861	27/33 (81.8)	23/30 (76.7)	0.614
Parenchymal
Baseline	45/45 (0)	39/39 (0)	Referent	40/40 (0)	52/52 (0)	Referent
1 month	18/44 (40.9)	4/37 (10.8)	0.002	11/38 (29.0)	14/50 (28.0)	0.922
6 month	19/39 (48.7)	8/27 (22.9)	0.021	19/34 (55.9)	21/47 (44.7)	0.320
12 month	20/41 (48.8)	7/36 (19.4)	0.007	20/34 (58.8)	29/49 (59.2)	0.974
Extraparenchymal
Baseline	28/28 (0)	30/30 (0)	Referent	11/11 (0)	13/13 (0)	Referent
1 month	10/28 (35.7)	7/30 (23.3)	0.301	5/11 (45.5)	5/13 (38.5)	1.000*
6 month	11/24 (45.8)	7/26 (26.9)	0.164	8/10 (80.0)	4/11 (36.4)	0.081*
12 month	15/26 (57.7)	13/26 (50.0)	0.578	6/10 (60.0)	7/13 (53.9)	1.000*

*Fisher’s exact test.